Metraipolis › archive › dc_80ebdd3d3e02

Heart failure reporting signals associated with concomitant mavacamten and CYP inhibitors in obstructive hypertrophic cardiomyopathy: a real-world… — Europe PMC PMID:42553383

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42553383
DOI
10.3389/fphar.2026.1846852
License (as archived)
solo-consultazione
Archived
2026-10-18T02:33:38.193Z
SHA-256 of the archived text
e22f3b89f85d65c36bc87b07da01943d50ac4cbc7dc6a14f9e19cc8dee74759d
Stable URL of this page
https://metraipolis.com/documento/dc_80ebdd3d3e02

How to cite

Heart failure reporting signals associated with concomitant mavacamten and CYP inhibitors in obstructive hypertrophic cardiomyopathy: a real-world… — Europe PMC PMID:42553383 — Europe PMC (en), https://europepmc.org/article/MED/42553383 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80ebdd3d3e02 (Metraipolis archive dc_80ebdd3d3e02, sha256 e22f3b89f85d65c36bc87b07da01943d50ac4cbc7dc6a14f9e19cc8dee74759d)
BibTeX
@misc{dc80ebdd3d3e02,
  title = {Heart failure reporting signals associated with concomitant mavacamten and CYP inhibitors in obstructive hypertrophic cardiomyopathy: a real-world… — Europe PMC PMID:42553383},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42553383},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80ebdd3d3e02; sha256 e22f3b89f85d65c36bc87b07da01943d50ac4cbc7dc6a14f9e19cc8dee74759d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42553383. Agents can read the archived copy with the MCP tool read_document.